Xiaocui Li

Prof. Dr. Xiaocui Li


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YJYuanyuan Jiang
Yuanyuan Jiang
YWYao Wei
Yao Wei
DYDaikang Yang
Daikang Yang
JYJiali Yao
Jiali Yao
QHQiping Hu
Qiping Hu
XLXiaocui Li
Xiaocui Li
The deficiency of TCOF1 is closely associated with multiple cellular dysfunctions, but its function in mitochondrial homeostasis and cytoskeletal regulation remains unclear. First, our research revealed that TCOF1 deficiency significantly inhibits tumor cell migration, suggesting TCOF1 plays a crucial role in cellular motility. Further studies demonstrated that TCOF1 deficiency disrupts normal F-actin polymerization, compromises cytoskeletal structural integrity, and impairs the dynamic assembly of F-actin, thereby affecting cell morphology and motility functions. Additionally, TCOF1 deficiency leads to mitochondrial dysfunction characterized by aberrant energy metabolism. Mechanistically, TCOF1 deficiency decreased the protein levels of p53, subsequently affecting mitochondrial biogenesis and functional maintenance, suggesting TCOF1 may regulate mitochondrial homeostasis via a p53-dependent pathway. Collectively, our study reveals TCOF1’s role in regulating tumor cell migration by influencing F-actin assembly and the p53-mitochondrial axis, playing a critical role in maintaining cytoskeletal dynamics and energy metabolism.

1 February 2026 in Acta Biochimica et Biophysica Sinica
Verified
Journal Article
Open access
PDF file
XLXiaocui Li
Xiaocui Li
YWYao Wei
Yao Wei
QCQiuchen Cheng
Qiuchen Cheng
SXSuyu Xiao
Suyu Xiao
SYSisi Yao
Sisi Yao
TZTingZheng Zhan
TingZheng Zhan
Anti-aging foods not only benefit elderly individuals but also drive the development of safe and effective natural drugs. Here, we report that the addition of total flavonoids of litchi seed (TFL) delays replicative senescence and stress-induced senescence. TFL alleviates the senescence-associated secretory phenotype (SASP) and reduces the degree of DNA damage caused by bleomycin (BLM). TFL also counteracts stress-induced pulmonary senescence and fibrosis. TFL reduces the protein level of p21 in mouse lung and alleviates pulmonary fibrosis. Transcriptome profiling further reveals that TFL plays a key role in its anti-aging mechanism by inhibiting the SASP. Mechanistically, TFL suppresses p65 protein expression, thereby inhibiting IL-1α and IL-1β and delaying cellular senescence. Gut microbiome analysis reveals that the abundance and functions of the mouse gut microbiome change after BLM infection and that TLF treatment reverses these changes. Overall, we provide a theoretical basis for the future application of TFL as a potential anti-aging product.

12 November 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
SYSisi Yao
Sisi Yao
WQWei Qiao
Wei Qiao
XLXiaocui Li
Xiaocui Li
ZZZhefeng Zhang
Zhefeng Zhang
FCFeiran Chen
Feiran Chen
TZTingZheng Zhan
TingZheng Zhan
Objective: To investigate the molecular mechanism by which interleukin-9 (IL-9) mediates liver fibrosis in schistosomiasis japonica through disruption of retinoic acid (RA) homeostasis, and to determine the protective effect of exogenous RA intervention against hepatic fibrosis in schistosomiasis japonica. Methods: Eighteen mice were randomly assigned to three groups: normal control (NC), Schistosoma japonicum (S. japonicum) infection (SJ), and RA intervention (SJ + RA). After 9 weeks of infection, liver fibrosis indicators were measured by qRT-PCR, Western blotting, ELISA, and immunohistochemistry. In cell experiments, hepatic stellate cells (HSC) were stimulated with IL-9, and an HSC–mast cell transwell co-culture system was established; HSC activation markers were examined, and key genes in the RA synthesis and metabolic pathways were identified by RNA-seq and verified by qRT-PCR. In addition, exogenous RA was applied to TGF-β1-activated HSC to investigate the inhibitory effect of RA on HSC activation. Results: Animal experiments showed that S. japonicum infection significantly upregulated the IL-9 mRNA expression in mouse liver tissues, increased the infiltration of IL-9-positive cells in the egg granuloma areas, and markedly reduced the hepatic RA content. Cell experiments showed that IL-9 stimulation alone did not directly induce HSC activation; however, in the HSC–mast cell co-culture system, IL-9 significantly upregulated the expression of HSC activation markers. RNA-seq analysis combined with qRT-PCR verified that, under HSC–mast cell co-culture conditions, the lipid droplet-associated proteins PLIN2 and PLIN3 were downregulated, with a more pronounced decrease in PLIN3, whereas RDH10, the rate-limiting enzyme of RA synthesis, was upregulated, approaching but not reaching statistical significance. Furthermore, in vivo and in vitro rescue experiments confirmed that exogenous RA supplementation effectively inhibited HSC activation and alleviated the liver fibrosis induced by S. japonicum infection. Conclusions: IL-9 suppressed PLIN2/3 expression and impaired RDH10-mediated RA expression via mast cell paracrine signaling. The resulting decline in local hepatic RA concentration disrupted the quiescent state of HSC, ultimately inducing aberrant HSC activation and thereby promoting the progression of liver fibrosis in schistosomiasis japonica.